Annual Review of Clinical Psychology
December 11, 2018
Joseph Wielgosz, Simon B. Goldberg, Tammi R. A. Kral et al.
441 citations
Mindfulness meditation is increasingly incorporated into mental health interventions, and theoretical concepts associated with it have influenced basic research on psychopathology. Here, we review the current understanding of mindfulness meditation through the lens of clinical neuroscience, outlining the core capacities targeted by mindfulness meditation and mapping them onto cognitive and...
Military behavioral health
November 29, 2018
Justin Havens, Jamie Hacker Hughes, F. McMaster et al.
Abstract Nightmares are a hallmark symptom of Post-Traumatic Stress Disorder (PTSD), affecting an estimated 90% of trauma-exposed adults. This article reports on a pragmatic randomized control trial to evaluate the effectiveness of an enhanced treatment approach called Planned Dream Interventions (PDI) compared with a standard sleep hygiene intervention. Ninety-two U.K. Armed Forces veterans...
Medicines
November 2, 2018
Helané Wahbeh
Background: Older adults have fewer physiological reserves and are more likely to be affected by stress. Mindfulness meditation has the potential to be an effective treatment for depression, but little research has been conducted on older adults. The primary objective of this study was to evaluate depression symptom changes in older adults (55–80 years old) taking an Internet Mindfulness...
Complementary Therapies in Clinical Practice
November 2018
Inger Burnett-Zeigler, Elizabeth M Waldron, Sunghyun Hong et al.
We evaluated the feasibility of using an activity monitor to support mindfulness practice, reduce self-reported stress and physiological indicators of stress. Adult women (N = 19) who previously participated in a mindfulness intervention wore an activity monitor for eight-weeks. The activity monitor notified them when they were stressed (based on standard deviation pulse pressure). Heart rate...
Neuropharmacology
November 1, 2018
Ben Sessa
61 citations
Alcohol use disorder represents a serious clinical, social and personal burden on its sufferers and a significant financial strain on society. Current treatments, both psychological and pharmacological are poor, with high rates of relapse after medical detoxification and dedicated treatment programs. The earliest historical roots of psychedelic drug-assisted psychotherapy in the 1950s were...
Thorax
October 18, 2018
Ann Marie Parker, Albahi M. Malik, Megan M. Hosey
4 citations
Depressive, anxiety and post-traumatic stress disorder (PTSD) symptoms are common, long-lasting and associated with worse quality of life among intensive care unit (ICU) survivors.1–4 There are few clinical trials evaluating interventions to improve these symptoms. Cox and colleagues evaluated the feasibility of a mobile mindfulness training application (App) to address psychological stress...
Journal of Clinical Psychopharmacology
October 10, 2018
Susan Schenk, David Newcombe
53 citations
Abstract Background For a number of mental health disorders, including posttraumatic stress disorders (PTSD), there are not many available treatment options. Recently, there has been renewed interest in the potential of methylenedioxymethamphetamine (MDMA) to restore function for patients with these disorders. The primary hypothesis is that MDMA, via prosocial effects, increases the ability of...
Journal of Psychosocial Nursing and Mental Health Services
October 1, 2018
Esther Bay, Roxane Raffin Chan
The current pre- and posttest intervention study is designed for individuals with chronic symptoms and stress associated with mild-to-moderate traumatic brain injury (TBI). The researchers' intent was to evaluate whether an 8-week mindfulness-based group therapy compared to health promotion active control group therapy reduces chronic stress, TBI symptoms, and depressive symptoms. Significant...
Frontiers in Immunology
September 21, 2018
José A. Crippa, Francisco Silveira Guimarães, Alline Cristina Campos et al.
312 citations
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subjective effects of marijuana. Objectives: The aim of the present review is to describe the main advances in the development of the experimental and clinical use of cannabidiol CBD in neuropsychiatry. Methods: A non-systematic search was performed for studies...
Psychiatric News
September 21, 2018
Lynne Lamberg
Back to table of contents Previous article Next article Clinical and Research NewsFull AccessSleep Specialists Assess Treatments for Nightmares in AdultsLynne LambergLynne LambergPublished Online:21 Sep 2018https://doi.org/10.1176/appi.pn.2018.8b24AbstractAn American Academy of Sleep Medicine panel evaluates behavioral, psychological, and pharmacologic options for treating nightmares in...